These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6515702)

  • 61. Hemodialysis does not affect erythrocyte sodium-lithium countertransport.
    Smith JB; Ash KO; Gregory MC; Sprowell WL; Hentschel WM; Williams RR
    Clin Chim Acta; 1984 Nov; 143(3):275-9. PubMed ID: 6499221
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Serum concentration of amantadine in the treatment of children with influenza type A infection].
    Kimura K; Komiyama O; Yamazaki M; Yamamoto K; Sugaya N
    Kansenshogaku Zasshi; 2000 Sep; 74(9):699-702. PubMed ID: 11068362
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
    Weintraub D; Sohr M; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
    Ann Neurol; 2010 Dec; 68(6):963-8. PubMed ID: 21154480
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 67. [Transformed and pathological red cells in endogenous intoxication and extracorporeal detoxication].
    Samoĭlov MV; Mishnev OD; Kudriavtsev IuV
    Arkh Patol; 2002; 64(5):36-40. PubMed ID: 12575540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Study of the level of adenine nucleotides and 2.3-DPG in erythrocytes during metabolic acidosis caused by renal failure].
    Przepalkowska B
    Pol Tyg Lek; 1977 Aug; 32(34):1313-6. PubMed ID: 20606
    [No Abstract]   [Full Text] [Related]  

  • 69. Determination of amantadine in human plasma by capillary gas chromatography using electron-capture detection following derivatization with pentafluorobenzoyl chloride.
    Rakestraw D
    J Pharm Biomed Anal; 1993 Aug; 11(8):699-703. PubMed ID: 8257734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Investigation of far red dyes for use in peroxyoxalate chemiluminescence detection and analysis of the cy5 derivative of amantadine hydrochloride in human plasma.
    Ellingson A; Karnes HT
    Biomed Chromatogr; 1998; 12(1):8-12. PubMed ID: 9470967
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of intravenous recombinant erythropoietin administration on plasma and erythrocyte magnesium concentrations in patients on hemodialysis.
    Allegra A; Corica F; Ientile R; Naso A; Corsonello A; Montalto G; Castagna L; Buemi M
    Nephron; 1996; 74(2):499-500. PubMed ID: 8893212
    [No Abstract]   [Full Text] [Related]  

  • 72. [Sodium, potassium, ATP, 2,3-diphosphoglycerate and inorganic phosphate levels in erythrocytes of patients on hemodialysis].
    Jabłońska-Skwiecińska E; Kowalska H; Staniszewska K
    Pol Arch Med Wewn; 1988 Mar; 79(3):140-4. PubMed ID: 2980658
    [No Abstract]   [Full Text] [Related]  

  • 73. Safety of perioperative treatment with intravenous amantadine in patients with Parkinson disease.
    Raz A; Lev N; Orbach-Zinger S; Djaldetti R
    Clin Neuropharmacol; 2013; 36(5):166-9. PubMed ID: 24045608
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.
    Cheng JT; Kahn T; Kaji DM
    J Clin Invest; 1984 Nov; 74(5):1811-20. PubMed ID: 6094614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin binding and glycolytic activity in erythrocytes from dialyzed and nondialyzed uremic patients.
    Weisinger JR; Contreras NE; Cajias J; Bellorin-Font E; Amair P; Guitierrez L; Sylva V; Paz-Martínez V
    Nephron; 1988; 48(3):190-6. PubMed ID: 3352846
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Treatment of parkinsonism with viregyt (amantadine)].
    Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
    Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
    [No Abstract]   [Full Text] [Related]  

  • 78. [Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents].
    Gospavić J; Vidaković Z
    Srp Arh Celok Lek; 1974 Jun; 102(6):447-57. PubMed ID: 4450143
    [No Abstract]   [Full Text] [Related]  

  • 79. Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).
    Pahwa R; Tanner CM; Hauser RA; Sethi K; Isaacson S; Truong D; Struck L; Ruby AE; McClure NL; Went GT; Stempien MJ
    Mov Disord; 2015 May; 30(6):788-95. PubMed ID: 25650051
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.